{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:07:25Z","timestamp":1775473645325,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-026-03618-8","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:27:42Z","timestamp":1768786062000},"page":"721-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significance of regional myocardial 99mTc-PYP uptake on clinical outcomes in wild-type transthyretin amyloid cardiomyopathy"],"prefix":"10.1007","volume":"42","author":[{"given":"Kyoko","family":"Unno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumori","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Saotome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"3618_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J (2024) Global epidemiology of heart failure. Nat Rev Cardiol 21:717\u2013734","journal-title":"Nat Rev Cardiol"},{"key":"3618_CR2","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet 387:2641\u20132654","journal-title":"Lancet"},{"key":"3618_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","volume":"17","author":"A Martinez-Naharro","year":"2020","unstructured":"Martinez-Naharro A, Baksi AJ, Hawkins PN, Fontana M (2020) Diagnostic imaging of cardiac amyloidosis. Nat Rev Cardiol 17:413\u2013426","journal-title":"Nat Rev Cardiol"},{"key":"3618_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jama.2024.0442","volume":"331","author":"FL Ruberg","year":"2024","unstructured":"Ruberg FL, Maurer MS (2024) Cardiac amyloidosis due to transthyretin protein: a review. JAMA 331:778\u2013791","journal-title":"JAMA"},{"key":"3618_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R et al (2016) Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 1:880\u201389","journal-title":"JAMA Cardiol"},{"key":"3618_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","volume":"11","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R et al (2018) Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. JACC Cardiovasc Imaging 11:234\u201342","journal-title":"JACC Cardiovasc Imaging"},{"key":"3618_CR7","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","volume":"39","author":"JD Gillmore","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A et al (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39:2799\u2013806","journal-title":"Eur Heart J"},{"key":"3618_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","volume":"102","author":"A Senapati","year":"2016","unstructured":"Senapati A, Sperry BW, Grodin JL, Kusunose K, Thavendiranathan P, Jaber W et al (2016) Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart 102:748\u2013754","journal-title":"Heart"},{"key":"3618_CR9","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1002\/ehf2.13541","volume":"8","author":"J Nativi-Nicolau","year":"2021","unstructured":"Nativi-Nicolau J, Judge DP, Hoffman JE, Gundapaneni B, Keohane D, Sultan MB et al (2021) Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT. ESC Heart Fail 8:3875\u20133884","journal-title":"ESC Heart Fail"},{"key":"3618_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","volume":"68","author":"MS Maurer","year":"2016","unstructured":"Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B et al (2016) Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin amyloid outcome Survey). J Am Coll Cardiol 68:161\u2013172","journal-title":"J Am Coll Cardiol"},{"key":"3618_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr 32:1\u201364","journal-title":"J Am Soc Echocardiogr"},{"key":"3618_CR12","first-page":"2404","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy Diagnosis Cardiac Transthyretin Amyloidosis Circulation 133:2404\u20132412","journal-title":"Nonbiopsy Diagnosis Cardiac Transthyretin Amyloidosis Circulation"},{"key":"3618_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"Bokhari S, Casta\u00f1o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS (2013) (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related Familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 6:195\u2013201","journal-title":"Circ Cardiovasc Imaging"},{"key":"3618_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s12350-022-03180-5","volume":"30","author":"T Ikoma","year":"2023","unstructured":"Ikoma T, Ohtani H, Ohno K, Iguchi K, Suwa K, Sawada M et al (2023) Diagnostic value of heart-to-mediastinum ratio in (99m)Tc-pyrophospate SPECT\/CT for transthyretin cardiac amyloidosis. J Nucl Cardiol 30:1374\u20131381","journal-title":"J Nucl Cardiol"},{"key":"3618_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.123.066524","volume":"149","author":"A Porcari","year":"2024","unstructured":"Porcari A, Fontana M, Canepa M, Biagini E, Cappelli F, Gagliardi C et al (2024) Clinical and prognostic implications of right ventricular uptake on bone scintigraphy in transthyretin amyloid cardiomyopathy. Circulation 149:1157\u20131168","journal-title":"Circulation"},{"key":"3618_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","volume":"9","author":"J Ternacle","year":"2016","unstructured":"Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P et al (2016) Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis. JACC Cardiovasc Imaging 9:126\u2013138","journal-title":"JACC Cardiovasc Imaging"},{"key":"3618_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.case.2019.09.009","volume":"4","author":"N Sawada","year":"2020","unstructured":"Sawada N, Daimon M, Abe H, Ushiku T, Kato TS, Morita H et al (2020) An autopsy case of cardiac amyloidosis with heterogeneous deposition of amyloid protein: a possible mechanism for relative apical sparing of longitudinal strain. CASE (Phila) 4:54\u201356","journal-title":"CASE (Phila)"},{"key":"3618_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s10554-025-03465-z","volume":"41","author":"B Dram\u00e9","year":"2025","unstructured":"Dram\u00e9 B, Martz M, El Ghannudi S, Hubele F, Hien MS, Bessac DM et al (2025) Left ventricular ejection fraction evaluation by (99m)Tc-DPD cardiac gated SPECT in patients with ATTR amyloidosis: feasibility and limitations. Int J Cardiovasc Imaging 41:1597\u2013603","journal-title":"Int J Cardiovasc Imaging"},{"key":"3618_CR19","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s10554-024-03158-z","volume":"40","author":"K Holcman","year":"2024","unstructured":"Holcman K, Kostkiewicz M, Szot W, \u0106miel B, Mr\u00f3z K, St\u0119pie\u0144 A et al (2024) Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness. Int J Cardiovasc Imaging 40:1693\u2013703","journal-title":"Int J Cardiovasc Imaging"},{"key":"3618_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00259-024-06981-7","volume":"52","author":"M Zhao","year":"2025","unstructured":"Zhao M, Calabretta R, Binder P, Yu J, Jiang Z, Nitsche C et al (2025) Clinical significance of quantitative assessment of right ventricular amyloid burden with [(99m)Tc]Tc-DPD SPECT\/CT in transthyretin cardiac amyloidosis. Eur J Nucl Med Mol Imaging 52:1073\u20131082","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3618_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133227","volume":"431","author":"K Holcman","year":"2025","unstructured":"Holcman K, Rubi\u015b P, \u0106miel B, Szot W, St\u0119pie\u0144-Wroniecka A, Graczyk K et al (2025) [(99m)Tc]Tc-DPD SPECT\/CT evaluation of right and left ventricular involvement in cardiac transthyretin amyloidosis. Int J Cardiol 431:133227","journal-title":"Int J Cardiol"},{"key":"3618_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/03007995.2012.754348","volume":"29","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maurer MS, Suhr OB (2013) THAOS - The transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 29:63\u201376","journal-title":"Curr Med Res Opin"},{"key":"3618_CR23","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16903","author":"K Holcman","year":"2025","unstructured":"Holcman K, Chmura \u0141, Rubi\u015b P, Stepie\u0144 A, Graczyk K, Kostkiewicz M (2025) Glu112Lys: a rare pathogenic transthyretin gene variant associated with negative scintigraphy findings. Pol Arch Intern Med. https:\/\/doi.org\/10.20452\/pamw.16903","journal-title":"Pol Arch Intern Med"},{"key":"3618_CR24","doi-asserted-by":"publisher","first-page":"e70057","DOI":"10.1111\/ene.70057","volume":"32","author":"A Dori","year":"2025","unstructured":"Dori A, Chorin O, Ruhrman-Shahar N, Fellner A, Alon T, Reznik-Wolf H et al (2025) Hereditary transthyretin amyloidosis in israel: genetic landscape and clinical characteristics. Eur J Neurol 32:e70057","journal-title":"Eur J Neurol"},{"key":"3618_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/13506129.2013.797890","volume":"20","author":"E Ihse","year":"2013","unstructured":"Ihse E, Rapezzi C, Merlini G, Benson MD, Ando Y, Suhr OB et al (2013) Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid 20:142\u201350","journal-title":"Amyloid"},{"key":"3618_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","volume":"121","author":"B Pilebro","year":"2016","unstructured":"Pilebro B, Suhr OB, N\u00e4slund U, Westermark P, Lindqvist P, Sundstr\u00f6m T (2016) (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Ups J Med Sci 121:17\u201324","journal-title":"Ups J Med Sci"},{"key":"3618_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/joim.12585","volume":"281","author":"OB Suhr","year":"2017","unstructured":"Suhr OB, Lundgren E, Westermark P (2017) One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition. J Intern Med 281:337\u2013347","journal-title":"J Intern Med"},{"key":"3618_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379:1007\u201316","journal-title":"N Engl J Med"},{"key":"3618_CR29","unstructured":"Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B et al (2024) Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. N Engl J Med"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-026-03618-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:59:21Z","timestamp":1775469561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-026-03618-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3618"],"URL":"https:\/\/doi.org\/10.1007\/s10554-026-03618-8","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YM reports the receipt of scholarship funds or donations from Abbott Medical Japan LLC, Medtronic Japan Co., Ltd., and BIOTRONIK JAPAN. The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"YM reports the receipt of scholarship funds or donations from Abbott Medical Japan LLC, Medtronic Japan Co., Ltd., and BIOTRONIK JAPAN. The other authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Disclosures"}}]}}